| Literature DB >> 27957532 |
Jonathan W VanRyzin1, Stacey J Yu2, Miguel Perez-Pouchoulen2, Margaret M McCarthy3.
Abstract
Microglia are the primary immune cells of the brain and function in multiple ways to facilitate proper brain development. However, our current understanding of how these cells influence the later expression of normal behaviors is lacking. Using the laboratory rat, we administered liposomal clodronate centrally to selectively deplete microglia in the developing postnatal brain. We then assessed a range of developmental, juvenile, and adult behaviors. Liposomal clodronate treatment on postnatal days 0, 2, and 4 depleted microglia with recovery by about 10 days of age and induced a hyperlocomotive phenotype, observable in the second postnatal week. Temporary microglia depletion also increased juvenile locomotion in the open field test and decreased anxiety-like behaviors in the open field and elevated plus maze. These same rats displayed reductions in predator odor-induced avoidance behavior, but increased their risk assessment behaviors compared with vehicle-treated controls. In adulthood, postnatal microglia depletion resulted in significant deficits in male-specific sex behaviors. Using factor analysis, we identified two underlying traits-behavioral disinhibition and locomotion-as being significantly altered by postnatal microglia depletion. These findings further implicate microglia as being critically important to the development of juvenile and adult behavior.Entities:
Keywords: behavior; liposomal clodronate; microglia; postnatal development
Mesh:
Substances:
Year: 2016 PMID: 27957532 PMCID: PMC5144556 DOI: 10.1523/ENEURO.0297-16.2016
Source DB: PubMed Journal: eNeuro ISSN: 2373-2822
Summary of statistical analyses.
| Line | Data structure | Type of test | Description of analysis | Test value | Effect size | Power or 95% CI | |
|---|---|---|---|---|---|---|---|
| a | Normal distribution | Welch’s | PN5 hippocampus: VEH vs. LC | 0.011 | 0.984 | ||
| b | Normal distribution | Welch's t-test | PN5 amygdala: VEH vs. LC | 0.005 | 0.596 | ||
| c | Normal distribution | Welch's t-test | PN5 cortex: VEH vs. LC | 0.054 | 0.991 | ||
| d | Normal distribution | Welch's t-test | PN5 hypothalamus: VEH vs. LC | 0.059 | 0.798 | ||
| e | Normal distribution | Welch's t-test | PN10 hippocampus: VEH vs. LC | 0.536 | 0.13 | ||
| f | Normal distribution | Welch's t-test | PN10 amygdala: VEH vs. LC | 0.036 | 0.457 | ||
| g | Normal distribution | Welch's t-test | PN10 cortex: VEH vs. LC | 0.293 | 0.702 | ||
| h | Normal distribution | Welch's t-test | PN10 hypothalamus: VEH vs. LC | 0.401 | 0.197 | ||
| i | Normal distribution | Welch's t-test | PN15 hippocampus: VEH vs. LC | 0.429 | 0.22 | ||
| j | Normal distribution | Welch's t-test | PN15 amygdala: VEH vs. LC | 0.36 | 0.225 | ||
| k | Normal distribution | Welch's t-test | PN15 cortex: VEH vs. LC | 0.384 | 0.274 | ||
| l | Normal distribution | Welch's t-test | PN15 hypothalamus: VEH vs. LC | 0.841 | 0.057 | ||
| m | Normal distribution | 3-way ANOVA | Main effect: sex | <0.001 | η2 = 0.068 | 1 | |
| n | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.785 | η2 = 0.072 | 0.058 | |
| o | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.974 | 1 | |
| p | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.108 | η2 = 0.004 | 0.375 | |
| q | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.027 | η2 = 0.287 | 0.633 | |
| r | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.992 | 1 | |
| s | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.161 | η2 = 0.001 | 0.341 | |
| t | Normal distribution | 3-way ANOVA | Main effect: sex | 0.288 | η2 = 0.033 | 0.183 | |
| u | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.541 | η2 = 0.011 | 0.092 | |
| v | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.155 | 1 | |
| w | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.24 | η2 = 0.031 | 0.263 | |
| x | Normal distribution | 3-way ANOVA | Main effect: sex | 0.676 | η2 = 0.004 | 0.069 | |
| y | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.003 | η2 = 0.217 | 0.868 | |
| z | Normal distribution | 2-way ANOVA | Main effect: age | 0.014 | η2 = 0.094 | 0.944 | |
| aa | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.11 | η2 = 0.051 | 0.489 | |
| bb | Normal distribution | 3-way ANOVA | Main effect: sex | 0.34 | η2 = 0.015 | 0.156 | |
| cc | Normal distribution | 2-way ANOVA | Main effect: treatment | <0.001 | η2 = 0.083 | 0.999 | |
| dd | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.367 | 1 | |
| ee | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.087 | η2 = 0.032 | 0.561 | |
| ff | Normal distribution | 3-way ANOVA | Main effect: sex | 0.955 | η2 < 0.000 | 0.05 | |
| gg | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.001 | η2 = 0.024 | 0.934 | |
| hh | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.493 | 1 | |
| ii | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.291 | η2 = 0.015 | 0.492 | |
| jj | Normal distribution | 3-way ANOVA | Main effect: sex | 0.3 | η2 = 0.008 | 0.176 | |
| kk | Normal distribution | 2-way ANOVA | Main effect: treatment | <0.001 | η2 = 0.723 | 1 | |
| ll | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.378 | 1 | |
| mm | Normal distribution | 2-way ANOVA | Interaction: treatment × age | <0.001 | η2 = 0.088 | 1 | |
| nn | Normal distribution | Welch's t-test | Post hoc: PN5 LC vs. VEH | 0.694; α = 0.05 | 0.066 | ||
| oo | Normal distribution | Welch's t-test | Post hoc: PN6 LC vs. VEH | 0.449; α = 0.025 | 0.117 | ||
| pp | Normal distribution | Welch's t-test | Post hoc: PN7 LC vs. VEH | 0.074; α = 0.0125 | 0.469 | ||
| Normal distribution | Welch's t-test | Post hoc: PN8 LC vs. VEH | 0.068; α = 0.01 | 0.456 | |||
| rr | Normal distribution | Welch's t-test | Post hoc: PN9 LC vs. VEH | 0.139; α = 0.01667 | 0.315 | ||
| ss | Normal distribution | Welch’s | Post hoc: PN10 LC vs. VEH | <0.001; α = 0.00714 | 0.984 | ||
| tt | Normal distribution | Welch’s | Post hoc: PN11 LC vs. VEH | <0.001; α = 0.0625 | 0.994 | ||
| uu | Normal distribution | Welch’s | Post hoc: PN12 LC vs. VEH | 0.004; α = 0.0083 | 0.864 | ||
| vv | Normal distribution | Welch’s | Post hoc: PN13 LC vs. VEH | <0.001; α = 0.0056 | 0.999 | ||
| ww | Normal distribution | Welch’s | Post hoc: PN14 LC vs. VEH | <0.001; α = 0.005 | 1 | ||
| xx | Normal distribution | 2-way ANOVA | Main effect: sex | 0.989 | η2 < 0.000 | 0.05 | |
| yy | Normal distribution | Welch’s | VEH vs. LC | <0.001 | 0.97 | ||
| zz | Normal distribution | 3-way ANOVA | Main effect: sex | 0.904 | η2 < 0.000 | 0.05 | |
| aaa | Normal distribution | 2-way ANOVA | Main effect: treatment | <0.001 | η2 = 0.043 | 0.97 | |
| bbb | Normal distribution | 2-way ANOVA | Main effect: age | 0.008 | η2 = 0.053 | 0.943 | |
| ccc | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.371 | η2 = 0.028 | 0.46 | |
| ddd | Normal distribution | 3-way ANOVA | Main effect: sex | 0.602 | η2 = 0.008 | 0.081 | |
| eee | Normal distribution | 2-way ANOVA | Main effect: age | <0.001 | η2 = 0.458 | 1 | |
| fff | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.786 | η2 = 0.002 | 0.058 | |
| ggg | Normal distribution | 2-way ANOVA | Interaction: treatment × age | 0.847 | η2 = 0.004 | 0.137 | |
| hhh | Normal distribution | 2-way ANOVA | Main effect: sex | 0.62 | η2 = 0.004 | 0.077 | |
| iii | Normal distribution | Welch’s | VEH vs. LC | <0.001 | 0.999 | ||
| jjj | Normal distribution | 2-way ANOVA | Main effect: sex | 0.188 | η2 = 0.043 | 0.257 | |
| kkk | Normal distribution | Welch’s | VEH vs. LC | 0.026 | 0.626 | ||
| lll | Normal distribution | 2-way ANOVA | Main effect: sex | 0.59 | η2 = 0.01 | 0.062 | |
| mmm | Normal distribution | Welch’s | VEH vs. LC | 0.083 | 0.441 | ||
| nnn | Normal distribution | One sample | VEH vs. 0.50 | 0.003 | 0.92 | ||
| ooo | Normal distribution | One sample | LC vs. 0.50 | 0.827 | 0.055 | ||
| ppp | Normal distribution | 2-way ANOVA | Main effect: sex | 0.059 | η2 = 0.135 | 0.477 | |
| qqq | Normal distribution | Welch’s | VEH vs. LC | 0.907 | 0.052 | ||
| rrr | Normal distribution | 2-way ANOVA | Main effect: sex | 0.674 | η2 = 0.006 | 0.069 | |
| sss | Normal distribution | Welch’s | VEH vs. LC | 0.094 | 0.416 | ||
| ttt | Normal distribution | 2-way ANOVA | Main effect: sex | 0.806 | η2 = 0.002 | 0.057 | |
| uuu | Normal distribution | Welch’s | VEH vs. LC | 0.006 | 0.807 | ||
| vvv | Normal distribution | 2-way ANOVA | Main effect: sex | 0.617 | η2 = 0.003 | 0.078 | |
| www | Normal distribution | Welch’s | VEH vs. LC | <0.001 | 1 | ||
| xxx | Normal distribution | 2-way ANOVA | Main effect: sex | 0.213 | η2 = 0.023 | 0.235 | |
| yyy | Normal distribution | Welch’s | VEH vs. LC | <0.001 | 0.999 | ||
| zzz | Normal distribution | 3-way ANOVA | Main effect: sex | 0.85 | η2 = 0.001 | 0.054 | |
| aaaa | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.003 | η2 = 0.158 | 0.875 | |
| bbbb | Normal distribution | 2-way ANOVA | Main effect: test phase | 0.018 | η2 = 0.04 | 0.677 | |
| cccc | Normal distribution | 2-way ANOVA | Interaction: treatment × test phase | 0.201 | η2 = 0.039 | 0.246 | |
| dddd | Normal distribution | 3-way ANOVA | Main effect: sex | 0.967 | η2 < 0.000 | 0.05 | |
| eeee | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.065 | η2 = 0.091 | 0.457 | |
| ffff | Normal distribution | 2-way ANOVA | Main effect: test phase | 0.448 | η2 = 0.016 | 0.116 | |
| gggg | Normal distribution | 2-way ANOVA | Interaction: treatment × test phase | 0.335 | η2 = 0.025 | 0.158 | |
| hhhh | Normal distribution | 3-way ANOVA | Main effect: sex | 0.99 | η2 < 0.000 | 0.05 | |
| iiii | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.004 | η2 = 0.204 | 0.999 | |
| jjjj | Normal distribution | 2-way ANOVA | Main effect: test phase | <0.001 | η2 = 0.389 | 0.999 | |
| kkkk | Normal distribution | 2-way ANOVA | Interaction: treatment × test phase | 0.013 | η2 = 0.097 | 0.719 | |
| llll | Normal distribution | Welch’s | Post hoc: VEH baseline vs. odor | <0.001; α = 0.0125 | 0.994 | ||
| mmmm | Normal distribution | Welch’s | Post hoc: LC baselline vs. odor | 0.038; α = 0.025 | 0.544 | ||
| nnnn | Normal distribution | Welch’s | Post hoc: baseline VEH vs. LC | 0.199; α = 0.05 | 0.237 | ||
| oooo | Normal distribution | Welch’s | Post hoc: odor VEH vs. LC | 0.005; α = 0.01667 | 0.824 | ||
| pppp | Normal distribution | 3-way ANOVA | Main effect: sex | 0.86 | η2 = 0.001 | 0.053 | |
| qqqq | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.001 | η2 = 0.25 | 0.92 | |
| rrrr | Normal distribution | 2-way ANOVA | Main effect: test phase | 0.006 | η2 = 0.146 | 0.814 | |
| ssss | Normal distribution | 2-way ANOVA | Interaction: treatment × test phase | <0.001 | η2 = 0.243 | 0.957 | |
| tttt | Normal distribution | Welch’s | Post hoc: VEH baseline vs. odor | 0.408; α = 0.05 | 0.099 | ||
| uuuu | Normal distribution | Welch’s | Post hoc: LC baselline vs. odor | 0.002; α = 0.01667 | 0.577 | ||
| vvvv | Normal distribution | Welch’s | Post hoc: baseline VEH vs. LC | 0.14; α = 0.025 | 0.329 | ||
| wwww | Normal distribution | Welch’s | Post hoc: odor VEH vs. LC | <0.001; α = 0.0125 | 0.99 | ||
| xxxx | Normal distribution | 3-way ANOVA | Main effect: sex | 0.86 | η2 = 0.001 | 0.053 | |
| yyyy | Normal distribution | 2-way ANOVA | Main effect: treatment | 0.007 | η2 = 0.113 | 0.801 | |
| zzzz | Normal distribution | 2-way ANOVA | Main effect: test phase | <0.001 | η2 = 0.135 | 0.989 | |
| aaaaa | Normal distribution | 2-way ANOVA | Interaction: treatment × test phase | 0.298 | η2 = 0.02 | 0.177 | |
| bbbbb | Normal distribution | 3-way ANOVA | Main effect: sex | 0.798 | η2 = 0.001 | 0.057 | |
| ccccc | Normal distribution | 2-way ANOVA | Main effect: treatment | <0.001 | η2 = 0.34 | 0.999 | |
| ddddd | Normal distribution | 2-way ANOVA | Main effect: test phase | 0.475 | η2 = 0.014 | 0.108 | |
| eeeee | Normal distribution | 2-way ANOVA | Interaction: treatment × test phase | 0.521 | η2 = 0.011 | 0.097 | |
| fffff | Non-normal | Wilcoxon rank sum test | Mount number: VEH vs. LC | 0.007 | HL = 18.889 | 5.999 to 35.999 | |
| ggggg | Non-normal | Wilcoxon rank sum test | Mount latency: VEH vs. LC | 0.011 | HL = -711.738 | -1180 to -25.999 | |
| hhhhh | Non-normal | Wilcoxon rank sum test | Intromission number: VEH vs. LC | 0.028 | HL = 9.0 | 4.33e-05 to 13.999 | |
| iiiii | Non-normal | Wilcoxon rank sum test | Intromission latency: VEH vs. LC | 0.009 | HL = -862.834 | -1167 to -121 | |
| jjjjj | Non-normal | Wilcoxon rank sum test | Ejaculation number: VEH vs. LC | 0.134 | HL < 0.000 | -6.933e-06 to 1 | |
| kkkkk | Non-normal | Wilcoxon rank sum test | Ejaculation latency: VEH vs. LC | 0.098 | HL = -131.621 | -663 to 5.161e-05 | |
| lllll | Normal distribution | Welch’s | Hops and darts: VEH vs. LC | 0.602 | 0.079 | ||
| mmmmm | Normal distribution | Welch’s | Solicitations: VEH vs. LC | 0.209 | 0.236 | ||
| nnnnn | Non-normal | Wilcoxon rank sum test | Lordosis quotient: VEH vs. LC | 1 | HL < 0.000 | -5.437e-06 to 2.74e-06 | |
| ooooo | Normal distribution | Welch’s | Factor 1: male vs. female | 0.621 | 0.077 | ||
| ppppp | Normal distribution | Welch’s | Factor 2: male vs. female | 0.499 | 0.105 | ||
| qqqqq | Normal distribution | Welch’s | Factor 3: male vs. female | 0.49 | 0.102 | ||
| rrrrr | Normal distribution | Welch’s | Factor 4: male vs. female | 0.572 | 0.085 | ||
| sssss | Normal distribution | Welch’s | Factor 1: VEH vs. LC | 0.003 | 0.865 | ||
| ttttt | Normal distribution | Welch’s | Factor 2: VEH vs. LC | <0.001 | 0.962 | ||
| uuuuu | Normal distribution | Welch’s | Factor 3: VEH vs. LC | 0.131 | 0.301 | ||
| vvvvv | Normal distribution | Welch’s | Factor 4: VEH vs. LC | 0.171 | 0.291 |
Figure 1.Treatment and behavioral testing timeline. Schematic depicting the ages at which treatments and behavioral testing were performed.
Figure 2.Microglia numbers are reduced after clodronate treatment and rapidly repopulate. Coronal sections of brains from PN5 VEH-treated (, , , ) and LC-treated (, , , ) rats. Representative images from sections labeled for Iba1 and counterstained with hematoxylin from the hippocampus (, ), cortex (, ), amygdala (, ), and hypothalamus (, ). Quantification of Iba1+ cell density in the hippocampus (), cortex (), amygdala (), and hypothalamus () at PN5, 10, and 15. Scale bars = 500 μm (, , , , , ) or 250 μm (, ). Bars indicate group means ± SEM for VEH-treated (black) and LC-treated (green) rats of both sexes. Open circles indicate data from individual female rats, and triangles, from male rats. *p < 0.05, **p < 0.01. n = 2–3 per treatment.
Figure 3.Microglia depletion alters the development of early reflexes, behaviors, and body weight throughout life. Body weight (in grams) in female () and male () rats measured daily from PN0 to PN90. , Time (in seconds) for rat pups to retreat from an edge (cliff aversion). , Time (in seconds) for rat pups to successfully right themselves (surface righting). , Duration (in seconds) rat pups hung from their forepaws before falling (wire hang). , Latency (in seconds) for rat pups to reverse orientation and face upward on an incline (negative geotaxis). , Latency (in seconds) for rat pups to leave a designated area (locomotion). Solid lines indicate group means for VEH-treated (black; ) and LC-treated (red; ) females, LC-treated males (blue; ), and LC-treated rats of both sexes (green; ). Shaded regions indicate ± SEM. **p < 0.01, ***p < 0.001. n = 18–20 per treatment.
Figure 4.Postnatal microglia depletion impairs nest-seeking behavior and decreases USV emission. Quantification of data from the two-choice nest-seeking task represented as average score per day (), average total score summed across all testing days (), and average latency (in seconds) to reach either goal arm of the testing apparatus (). , Quantification of the number of USVs produced by pups when separated from the mother on PN8. Solid lines and bars indicate group means for VEH-treated (black) and LC-treated (green) rats of both sexes. Shaded regions and error bars indicate ± SEM. Open circles represent data from individual rats. Horizontal dashed line indicates score equal to chance (, ). ***p < 0.001. n = 18–20 () and 13–14 () per treatment.
Figure 5.Postnatal microglia depletion induces selective memory impairment in juvenile rats. , Percentage successful spontaneous alternations in a T-maze from PN25 to PN29. , Social recognition index calculated on PN30 after a 30-min retention interval. , Novel object recognition index calculated after a 1-h (PN26) and 24-h (PN27) retention interval. Bars indicate group means ± SEM for VEH-treated (black) and LC-treated (green) rats of both sexes. Open circles represent data from individual rats. Horizontal dashed line indicates score equal to chance (). *p < 0.05. #p < 0.01 compared with chance. n = 18–20 () and 13–16 (, ) per treatment.
Figure 6.Postnatal microglia depletion increases locomotion, center time in the open field, and open arm time in the elevated plus maze in juvenile rats. Center time (; in seconds) and gridline crosses () in an open field arena on PN25. , Percentage of time in the open arms of an elevated plus maze on PN32. Bars indicate group means ± SEM for VEH-treated (black) and LC-treated (green) rats of both sexes. Open circles represent data from individual rats. **p < 0.01, ***p < 0.001. n = 18–20 per treatment.
Figure 7.Microglia-depleted animals exhibit decreased fear and avoidance but display risk-assessing behaviors. Quantification of data from the predator odor exposure test (PN33) for time (in seconds) spent in various behaviors including time behind the barrier (), freezing behavior (), stretch-attend behavior (), stretch-locomotion behavior (), number of stimulus cloth approaches (), and stimulus cloth interaction duration (). Bars indicate group means ± SEM for VEH-treated (black) and LC-treated (green) rats of both sexes. Open circles represent data from individual rats. *p < 0.05, **p < 0.01, ***p < 0.001. n = 18–20 per treatment.
Figure 8.Postnatal microglia depletion induces deficits in adult male sex behaviors. Quantification of various components of male sex behavior including number of mounts (), latency to first mount (), number of intromissions (), latency to first intromission (), number of ejaculations (), and latency to first ejaculation (). Solid bars indicate group means ± SEM for VEH-treated (black) and LC-treated (blue) male rats. Open circles represent data from individual rats. *p < 0.05, **p < 0.01. n = 7–10 per treatment.
Figure 9.Adult female sex behavior is unchanged after postnatal microglia depletion. Quantification of female sexual proceptivity: number of hops and darts () and solicitations () and receptivity lordosis quotient (). Solid bars indicate group means ± SEM for VEH-treated (black) and LC-treated (red) female rats. Open circles represent data from individual rats. n = 9–10 per treatment.
Figure 10.Factor analysis results. () Behavior factor loadings for each named factor. Longer, saturated bars indicate stronger loadings, with green indicating positive loading and black indicating negative loading. () Loading scores for VEH and LC rats plotted for each factor. The values in parentheses represent the percentage of total variance accounted for by each factor. Bars indicate group means ± SEM for VEH-treated (black) and LC-treated (green) rats of both sexes. **p < 0.01, ***p < 0.001. n = 13–16 per treatment.